Revolution Medicines announces closing of concurrent upsized public offerings with aggregate gross proceeds of approximately $2.2 billion, including full exercise of underwriters' option to purchase additional shares

Published: 2026-04-17 16:37:47 ET RVMD

Published on 04/17/2026 at 04:37 pm EDT